Literature DB >> 1089836

Exocrine pancreatic dysfunction in guinea pigs with diabetes mellitus.

M W Balk, C M Lang, W J White, B L Munger.   

Abstract

In this study, 37 guinea pigs were classified, on the basis of histologic examination of the pancreas, into three categories: nondiabetic, latent diabetic, and overt diabetic. In order to compare the exocrine pancreatic function in these three groups of animals, pancreatic secretion was collected from each animal following an intravenous infusion of secretin and pancreozymin. Pancreatic enzyme activity, bicarbonate concentration, and the total volume of pancreatic secretion were all significantly decreased in guinea pigs with overt diabetes, but not in those with latent diabetes mellitus. Pancreatic histologic changes characteristic of both latent and overt diabetes were beta-cell hyperplasia and generalized fatty degeneration of the acini. Only the animals with overt diabetes showed total degranulation and severe vacuolation of theta-cells. The same type of exocrine pancreatic dysfunction observed in guinea pigs with spontaneous overt diabetes mellitus is found in human diabetics, and is particularly common in the juvenile type. The guinea pig, therefore, appears to be a suitable animal model for the study of human juvenile diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089836

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  2 in total

1.  Lipid abnormalities in pancreatic tissue of streptozotocin-induced diabetic rats.

Authors:  E Levy; C C Roy; G Lepage; M Bendayan
Journal:  Lipids       Date:  1988-08       Impact factor: 1.880

2.  Insulin is necessary for the hypertrophic effect of cholecystokinin-octapeptide following acute necrotizing experimental pancreatitis.

Authors:  Peter Hegyi; Zoltan Rakonczay; Reka Sari; Laszlo Czako; Norbert Farkas; Csaba Gog; Jozsef Nemeth; Janos Lonovics; Tamas Takacs
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.